M. de Locht

Side-effects of desferrioxamine in dialysis patients.

J. Boelaert, M. de Locht, 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Iron uptake from ferrioxamine and from ferrirhizoferrin by germinating spores of Rhizopus microsporus.

Y. Schneider, J. Boelaert, M. de Locht, 1994, Biochemical pharmacology.

Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect.

R. Crichton, Y. Schneider, J. V. van Cutsem, 1994, Kidney international.

Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies.

Y. Schneider, J. V. van Cutsem, H. W. Landuyt, 1993, The Journal of clinical investigation.

The effect of deferoxamine on different zygomycetes.

Y. Schneider, J. Boelaert, M. de Locht, 1994, The Journal of infectious diseases.